The core value driver remains KT-621, Kymera’s STAT6-targeting program. “STAT6 remains [the] primary driver to the story,” ...

Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

Labcorp (LH), and Gilead (GILD) rise as Supreme Court upholds right to free preventive care under Obamacare. Read more here.

TotalEnergies SE (EPA:TTEF) revealed on Friday that it has acquired a 25% interest in Block 53 offshore Suriname from Spain’s Moeve, formerly CEPSA.

Boeing is entering a new phase of recovery that could support a market reassessment of its stock, according to analysts at Redburn.

Cineplex Inc . (TSX:CGX) stock rose 5% Friday after the company announced that longtime President and CEO Ellis Jacob will retire on December 31, 2026.

Recombinant therapeutics market surges to $960.4B by 2035, fueled by biotech advances, targeted therapies, and rising global ...